What the research shows
A systematic review and meta-regression of weight trajectories after stopping GLP-1 receptor agonist treatment found that roughly 60% of the weight lost during treatment was regained within a year of stopping, with modeled long-term regain plateauing at over 70% of the treatment-phase loss.
Why regain happens so quickly after stopping
These medications work partly by altering appetite signaling. When the medication is discontinued, the appetite suppression effect fades, while the underlying behavioral and environmental factors that originally drove weight gain are often still present, allowing regain to begin relatively quickly.
What this means for treatment planning
The research pattern suggests these medications are most effective as part of a long-term, potentially indefinite management plan, rather than a short course intended to "reset" weight before stopping -- similar in some ways to how blood pressure medication is managed as an ongoing treatment rather than a temporary fix.
The maintenance-plan gap
Regardless of how weight is initially lost -- medication, diet, or both -- the same core maintenance factors from broader weight-regain research apply afterward: consistent self-weighing, a defined maintenance calorie target, and continued activity appear to matter more than the specific method used to lose the weight originally.